These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15043208)

  • 41. Host ABCE1 is at plasma membrane HIV assembly sites and its dissociation from Gag is linked to subsequent events of virus production.
    Dooher JE; Schneider BL; Reed JC; Lingappa JR
    Traffic; 2007 Mar; 8(3):195-211. PubMed ID: 17233757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disparate Contributions of Human Retrovirus Capsid Subdomains to Gag-Gag Oligomerization, Virus Morphology, and Particle Biogenesis.
    Martin JL; Mendonça LM; Angert I; Mueller JD; Zhang W; Mansky LM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein.
    Pornillos O; Alam SL; Davis DR; Sundquist WI
    Nat Struct Biol; 2002 Nov; 9(11):812-7. PubMed ID: 12379843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of human immunodeficiency virus type-1 Gag-TSG101 interaction inhibitors by high-throughput screening.
    Siarot L; Chutiwitoonchai N; Sato H; Chang H; Sato H; Fujino M; Murakami T; Aono T; Kodama E; Kuroda K; Takei M; Aida Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2970-2976. PubMed ID: 30126636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
    Sandefur S; Smith RM; Varthakavi V; Spearman P
    J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly.
    Alfadhli A; Dhenub TC; Still A; Barklis E
    J Virol; 2005 Dec; 79(23):14498-506. PubMed ID: 16282449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100.
    Holm K; Weclewicz K; Hewson R; Suomalainen M
    J Virol; 2003 Apr; 77(8):4805-17. PubMed ID: 12663787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
    Ono A; Demirov D; Freed EO
    J Virol; 2000 Jun; 74(11):5142-50. PubMed ID: 10799589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.
    Patnaik A; Wills JW
    J Virol; 2002 Mar; 76(6):2789-95. PubMed ID: 11861846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.
    Zhang WH; Hockley DJ; Nermut MV; Morikawa Y; Jones IM
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():743-51. PubMed ID: 8627263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
    Joshi A; Nagashima K; Freed EO
    J Virol; 2006 Aug; 80(16):7939-51. PubMed ID: 16873251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
    Demirov DG; Ono A; Orenstein JM; Freed EO
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
    Garrus JE; von Schwedler UK; Pornillos OW; Morham SG; Zavitz KH; Wang HE; Wettstein DA; Stray KM; Côté M; Rich RL; Myszka DG; Sundquist WI
    Cell; 2001 Oct; 107(1):55-65. PubMed ID: 11595185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways.
    Chu H; Wang JJ; Spearman P
    Curr Top Microbiol Immunol; 2009; 339():67-84. PubMed ID: 20012524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
    Melamed D; Mark-Danieli M; Kenan-Eichler M; Kraus O; Castiel A; Laham N; Pupko T; Glaser F; Ben-Tal N; Bacharach E
    J Virol; 2004 Sep; 78(18):9675-88. PubMed ID: 15331700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blocking HIV-1 virus assembly.
    Vogt VM
    Nat Struct Mol Biol; 2005 Aug; 12(8):638-9. PubMed ID: 16077724
    [No Abstract]   [Full Text] [Related]  

  • 58. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The HIV-TSG101 interface: recent advances in a budding field.
    Freed EO
    Trends Microbiol; 2003 Feb; 11(2):56-9. PubMed ID: 12598123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.
    Okumura A; Lu G; Pitha-Rowe I; Pitha PM
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1440-5. PubMed ID: 16434471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.